Sustainable Construction through Tradition: Inventory of Cob Buildings in the Guérande Peninsula (France).

Autor: Poullain, Philippe¹ (AUTHOR) philippe.poullain@univ-nantes.fr, Miranda-Santos, Marta² (AUTHOR) marta.miranda-santos@rouen.archi.fr, Hilton, Alison³ (AUTHOR) alison.hilton@gmail.com, Hamard, Erwan⁴ (AUTHOR) erwan.hamard@univ-eiffel.fr, Mouraud, Corentin³ (AUTHOR) corentinmouraud@orange.fr

Publikováno v: Heritage (2571-9408). Sep2024, Vol. 7 Issue 9, p4768-4789. 22p.

Synthesis and characterization of nanostructured ternary MAX-phase thin films prepared by magnetron sputtering as precursors for twodimensional MXenes

Autor: Miranda Marti, Marta

MAX phase thin films can be fabricated through firstly depositing a precursor thin film consisting of the initial elements M, A, and X close to the MAX phase stoichiometry employing physical vapor deposition techniques with a subsequent thermal annea

Externí odkaz: http://hdl.handle.net/20.500.12404/24449

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

On the influence of narrative in the perception of raw earth construction

Autor: Miranda Santos, Marta, Lescop, Laurent, Hamard, Erwan, Navarro Ezquerra, Antonia

Publikováno v: UPCommons. Portal del coneixement obert de la UPC
Universitat Politècnica de Catalunya (UPC)

Raw earth has fundamental environmental values, including low embodied energy, reduced greenhouse emissions, andendless reuse. These benefits are driving the growing interest in earth-based construction projects and research (Moreland Charef, 2019).M

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::6c5274dc950847c8f2681ba0e91ecd44
http://hdl.handle.net/2117/370639

Naltrexone as an adjunctive antidepressant treatment in patients with depression and alcohol use disorder. Systematic review

Autor: Cala, Natalia Juliana, Miranda-Fernández, Marta-Catalina

Publikováno v: Social M de S y P, Colciencias, Universidad Javeriana. Encuesta Nacional de Salud Mental 2015 [Internet]. Vol. Tomo I, Ministerio de Salud y Proteccion Social. 2015. 344 p. Available from: https://www.javerianacali.edu.co/sites/ujc/files/node/field-documents/field_document_file/saludmental_final_tomoi_color.pdf
Andersen AM, Pietrzak RH, Kranzler HR, Ma L, Zhou H, Liu X, et al. Polygenic Scores for Major Depressive Disorder and Risk of Alcohol Dependence. JAMA psychiatry. 2017;74(11):1153–60.
Sullivan LE, Fiellin DA, O’Connor PG. The prevalence and impact of alcohol problems in major depression: A systematic review. Am J Med. 2005;118(4):330–41.
Foo JC, Streit F, Treutlein J, Ripke S, Witt SH, Strohmaier J, et al. Shared genetic etiology between alcohol dependence and major depressive disorder. Psychiatr Genet. 2018;28(4):66–70.
HR K, J VK. Efficacy of Naltrexone and Acamprosate for Alcoholism Treatment: a Meta-Analysis. Alcohol Clin Exp Res. 2001;25(9):1335–41.
Sthal S. Stahl ’ s Essential Psychopharmacology Neuroscientific Basis and Practial Applications. Fourth edi. 2013.
SE K, RA K, EA Y, J-K Z. Dysregulation of Endogenous Opioid Emotion Regulation Circuitry in Major Depression in Women. Arch Gen Psychiatry [Internet]. 2006;63(11):1199–208. Available from: http://onlinelibrary.wiley.com/o/cochrane/clcentral/articles/481/CN-00573481/frame.html
Pettinati HM, Oslin DW, Kampman KM, Dundon WD, Xie H, Gallis TL, et al. A Double-Blind, Placebo-Controlled Trial Combining Sertraline and Naltrexone for Treating Co-Occurring Depression and Alcohol Dependence. Am J Psychiatry [Internet]. 2010 Jun;167(6):668–75. Available from: http://psychiatryonline.org/doi/abs/10.1176/appi.ajp.2009.08060852
Foulds JA, Sellman JD, Adamson SJ, Boden JM, Mulder RT, Joyce PR. Depression outcome in alcohol dependent patients: An evaluation of the role of independent and substance-induced depression and other predictors. J Affect Disord [Internet]. 2015;174:503–10. Available from: http://dx.doi.org/10.1016/j.jad.2014.11.052
Hulley SB, Newman TB, Cumming SR. Cómo empezar: anatomía y fisiología de las investigaciones clínicas. Diseño Investig clínicas. 2011;(March):6–17.
Eşel E, Dinç K. Neurobiology of alcohol dependence and implications on treatment. Turk Psikiyatr Derg. 2017;28(1):1–10.
Soyka M, Müller CA. Pharmacotherapy of alcoholism–an update on approved and off-label medications. Expert Opin Pharmacother [Internet]. 2017;18(12):1187–99. Available from: https://doi.org/10.1080/14656566.2017.1349098
Nava-Mesa MO, Lamprea MR, Múnera A. Divergent short-and long-term effects of acute stress in object recognition memory are mediated by endogenous opioid system activation. Neurobiol Learn Mem [Internet]. 2013;106(September):185–92. Available from: http://dx.doi.org/10.1016/j.nlm.2013.09.002
Thompson A, Owens L, Pushpakom SP, Faizal M, Pirmohamed M. Pharmacotherapy for alcohol dependence: A stratified approach. Pharmacol Ther [Internet]. 2015;153:10–24. Available from: http://dx.doi.org/10.1016/j.pharmthera.2015.05.010
Nava-Mesa MO, Téllez-Arévalo A, Rojas-Kozhakin D, Calderón-Ospina CA. Usos terapéuticos potenciales de los antagonistas opioides: Fisiopatología y evidencia preclínica. Rev Colomb Ciencias Químico Farm. 2015;44(3):322–58.
Manual S, Disorders M, Edition F. Pharmacological options for maintenance treatment of opioid dependence include opioid agonists and antagonists. Drugs Ther Perspect. 2012;28(8):11–4.
Torres-Berrio A, Nava-Mesa MO. The opioid system in stress-induced memory disorders: From basic mechanisms to clinical implications in post-traumatic stress disorder and Alzheimer’s disease. Prog Neuro-Psychopharmacology Biol Psychiatry. 2019;88(August 2018):327–38.
Duffy KA, Mclaughlin KA, Green PA. Early life adversity and health-risk behaviors: Proposed psychological and neural mechanisms. Ann N Y Acad Sci. 2018;1–19.
Hurtado AU, León ML, Gonzales L, León A, De Armas J, Rodriguez G. Bases neurobiológicas de la adicción al alcohol Neurobiological Basis of Alcohol Addiction. Rev Finlay [Internet]. 2014;4:40–53. Available from: http://www.revfinlay.sld.cu/index.php/finlay/article/view/253%5CnResumen
Gold PW, Machado-vieira R, Pavlatou MG. Clinical and Biochemical Manifestations of Depression : Relation to the Neurobiology of Stress. 2015;2015:7–9.
Petrakis I, Ralevski E, Nich C, Levinson C, Carroll K, Poling J, et al. Naltrexone and disulfiram in patients with alcohol dependence and current depression. J Clin Psychopharmacol. 2007;27(2):160–5.
Cooperative A, Program S, City U. The Ne w E n g l a nd Jo u r n a l o f Me d ic i ne NALTREXONE IN THE TREATMENT OF ALCOHOL DEPENDENCE. 2001;345(24):1734–9.
Pettinati HM, Oslin DW, Kampman KM, Dundon WD, Xie H, Gallis TL, et al. A double-blind, placebo-controlled trial combining sertraline and naltrexone for treating co-occurring depression and alcohol dependence. Am J Psychiatry. 2010 Jun;167(6):668–75.
Adamson SJ, Sellman JD, Foulds JA, Frampton CMA, Deering D, Dunn A, et al. A randomized trial of combined citalopram and naltrexone for nonabstinent outpatients with co-occurring alcohol dependence and major depression. J Clin Psychopharmacol. 2015;35(2):143–9.
Oslin DW. Treatment of late-life depression complicated by alcohol dependence. Am J Geriatr Psychiatry [Internet]. 2005;13(6):491–500. Available from: http://dx.doi.org/10.1097/00019442-200506000-00008
Rohan KJ, Rough JN, Evans M, Ho SY, Meyerhoff J, Roberts LM, et al. A protocol for the Hamilton Rating Scale for Depression: Item scoring rules, Rater training, and outcome accuracy with data on its application in a clinical trial. J Affect Disord [Internet]. 2016;200:111–8. Available from: http://dx.doi.org/10.1016/j.jad.2016.01.051
World Medical Asociation (AMM). Declaración de Helsinki de la AMM-Principios éticos para las investigaciones médicas en seres humanos. World Med Assoc Inc. 2013;1–8.
Ministerio de Salud. Resolución 8430 de 1993. Minist Salud y Protección Soc República Colomb. 1993;1993(Octubre 4):1–19.
Pal BK, Sahedur Rahman M. Sensitive spectrofluorimetric determination of ruthenium at nanotrace levels using 2-(α-pyridyl) thioquinaldinamide [PTQA]. Talanta. 1999;48(5):1075–84.
Borenstein M, Hedges LV, Higgins JPT RH. Publication bias. In: Introduction to meta-analysis. John Wiley & Sons; 2009. p. 77–94.
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario

La naltrexona es un antagonista opioide usado, no solo para el manejo de la desintoxicación y mantenimiento en pacientes con adicción a opioides, sino también para el tratamiento de la dependencia a alcohol. En estudios con pacientes con depresió

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0867bd4f5ca4b5f13d26da4fefda7c8d